Biofrontera Future Growth
Future criteria checks 5/6
Biofrontera is forecast to grow earnings and revenue by 65.8% and 21.8% per annum respectively while EPS is expected to grow by 80.7% per annum.
Key information
65.8%
Earnings growth rate
80.7%
EPS growth rate
| Pharmaceuticals earnings growth | 23.4% |
| Revenue growth rate | 21.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 19 Mar 2024 |
Recent future growth updates
Recent updates
Biofrontera Inc. (NASDAQ:BFRI) Not Doing Enough For Some Investors As Its Shares Slump 28%
Dec 30
The Market Doesn't Like What It Sees From Biofrontera Inc.'s (NASDAQ:BFRI) Revenues Yet As Shares Tumble 43%
Nov 13Can Biofrontera (NASDAQ:BFRI) Afford To Invest In Growth?
Oct 18Biofrontera announces preliminary Q3 product revenue, stock falls ~7% after hours
Oct 05Biofrontera gets notice of allowance for U.S. patent covering a nanoemulsion formulation
Sep 06Biofrontera GAAP EPS of -$0.05, revenue of $4.5M; reaffirms FY22 guidance
Aug 12Biofrontera announces 2Q prelim product revenues
Jul 12Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 65 | 7 | N/A | N/A | 1 |
| 12/31/2025 | 50 | -3 | N/A | 1 | 2 |
| 12/31/2024 | 41 | -16 | N/A | -2 | 2 |
| 12/31/2023 | 34 | -20 | -25 | -25 | N/A |
| 9/30/2023 | 34 | -26 | -24 | -24 | N/A |
| 6/30/2023 | 29 | -23 | -28 | -28 | N/A |
| 3/31/2023 | 28 | -14 | -18 | -18 | N/A |
| 12/31/2022 | 29 | -1 | -16 | -16 | N/A |
| 9/30/2022 | 28 | -12 | -29 | -29 | N/A |
| 6/30/2022 | 28 | -26 | -24 | -24 | N/A |
| 3/31/2022 | 29 | -29 | -25 | -25 | N/A |
| 12/31/2021 | 24 | -38 | -27 | -27 | N/A |
| 9/30/2021 | 24 | -23 | -6 | -6 | N/A |
| 6/30/2021 | 22 | -10 | -6 | -6 | N/A |
| 3/31/2021 | 19 | -10 | -9 | -9 | N/A |
| 12/31/2020 | 19 | -11 | -12 | -12 | N/A |
| 12/31/2019 | 26 | -11 | -38 | -38 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BFRI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
Earnings vs Market: BFRI is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: BFRI is expected to become profitable in the next 3 years.
Revenue vs Market: BFRI's revenue (21.8% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: BFRI's revenue (21.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BFRI's Return on Equity is forecast to be high in 3 years time